Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02313077
What this trial is testing

A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 87
Large-scale testing (Phase 3)UnknownNCT04152486
What this trial is testing

Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 20,426
Testing effectiveness (Phase 2)Study completedNCT02575456
What this trial is testing

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

Who this might be right for
Ebola Disease
Jiangsu Province Centers for Disease Control and Prevention 500
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Early research (Phase 1)WithdrawnNCT02389192
What this trial is testing

Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05909358
What this trial is testing

Solidarity/Tokomeza Ebola Trial

Who this might be right for
Sudan Ebola Virus Vaccines
Makerere University 2,121
Early research (Phase 1)Study completedNCT00605514
What this trial is testing

Ebola and Marburg Virus Vaccines

Who this might be right for
Ebola VaccinesMarburg Virus DiseaseEbola Virus Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Testing effectiveness (Phase 2)Study completedNCT02287480
What this trial is testing

VSV-ZEBOV Geneva Vaccine Trial

Who this might be right for
Ebolavirus Disease
University Hospital, Geneva 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05202288
What this trial is testing

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 132
Early research (Phase 1)Study completedNCT02718469
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Who this might be right for
Ebola Virus Disease
Auro Vaccines LLC 38
Testing effectiveness (Phase 2)Study completedNCT02329054
What this trial is testing

Efficacy of Favipiravir Against Ebola (JIKI)

Who this might be right for
Ebola Virus Disease
Institut National de la Santé Et de la Recherche Médicale, France 126
Testing effectiveness (Phase 2)Study completedNCT02818582
What this trial is testing

GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

Who this might be right for
Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 38
Not applicableEnded earlyNCT04250168
What this trial is testing

Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response

Who this might be right for
Sepsis BacterialEbola Virus DiseaseBloodstream Infection
Institute of Tropical Medicine, Belgium 43
Early research (Phase 1)Study completedNCT02269423
What this trial is testing

Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 39
Early research (Phase 1)Study completedNCT02533791
What this trial is testing

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 110
Early research (Phase 1)Study completedNCT02354404
What this trial is testing

Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Study completedNCT02416453
What this trial is testing

Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults

Who this might be right for
Ebola Viral Disease
Janssen Vaccines & Prevention B.V. 423
Testing effectiveness (Phase 2)Study completedNCT02363322
What this trial is testing

Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

Who this might be right for
Ebola Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 72
Next Page